| 标题 |
Mezigdomide (CC-92480), a Potent, Novel Cereblon E3 Ligase Modulator (CELMoD), Combined with Dexamethasone (DEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results from the Dose-Expansion Phase of the CC-92480-MM-001 Trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Blood 作者:Paul G. Richardson; Suzanne Trudel; Hang Quach; Rakesh Popat; Sagar Lonial; et al 出版日期:2022-11-29 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)